Wednesday, June 24, 2020

Zydus Cadila gets USFDA nod to market generic antihistamine tablets

Zydus Cadila gets USFDA nod to market generic antihistamine tablets The company has received final approval from the United States Food and Drug Administration (USFDA) to market Meclizine hydrochloride tablets in the strengths of 12.5 mg and 25 mg, the company said in a statement.

from Moneycontrol Business News https://ift.tt/2YXPC0g
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...